BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27422767)

  • 41. Necrolytic migratory erythema.
    Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
    J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Glucagonoma. A tumor disease with multiple clinical manifestations].
    Andersson K; Wängberg B; Tisell LE; Nilsson O; Fjälling M; Forssell-Aronsson E; Ahrén B; Ahlman H
    Lakartidningen; 1996 Aug; 93(35):2935-9. PubMed ID: 8815353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Necrolytic migratory erythema associated with a glucagon-producing primary hepatic neuroendocrine carcinoma in a cat.
    Asakawa MG; Cullen JM; Linder KE
    Vet Dermatol; 2013 Aug; 24(4):466-9, e109-10. PubMed ID: 23738981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Necrolytic migratory erythema without glucagonoma associated with hepatitis B.
    Kitamura Y; Sato M; Hatamochi A; Yamazaki S
    Eur J Dermatol; 2005; 15(1):49-51. PubMed ID: 15701595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A human pancreatic glucagonoma, ultrastructural, immunocytochemical and radioimmunological investigations (author's transl)].
    Voigt JJ; Hollande E; Pradayrol L; Vinel JP; Gorguet B
    Ann Pathol; 1981; 1(4):287-97. PubMed ID: 6274365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Necrolytic migratory erythema].
    Dandrifosse JF; Dandrifosse AC; Piérard G; Scheen AJ; Dandrifosse G
    Rev Med Liege; 1998 Dec; 53(12):778-83. PubMed ID: 9927878
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid resolution of necrolytic migratory erythema after glucagonoma resection.
    Smith AP; Doolas A; Staren ED
    J Surg Oncol; 1996 Apr; 61(4):306-9. PubMed ID: 8628004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Benign pancreatic glucagonoma and recurrent pulmonary embolism with fatal course in a 36-year old man].
    Sprogøe-Jakobsen U; Karkov JN
    Ugeskr Laeger; 1991 Oct; 153(43):3015-6. PubMed ID: 1801389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Paediatric necrolytic migratory erythema as a presenting sign of glucagonoma syndrome.
    Luber AJ; Ackerman LS; Culpepper KS; Buschmann CM; Koep LJ
    Br J Dermatol; 2016 May; 174(5):1092-1095. PubMed ID: 26585841
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is necrolytic migratory erythema due to glucagonoma a misnomer? A more apt name might be mucosal and intertriginous erosive dermatitis.
    Grewal P; Salopek TG
    J Cutan Med Surg; 2012; 16(2):76-82. PubMed ID: 22513058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dermatologic correlates of selected metabolic events.
    Cohen JB; Janniger CK; Piela Z; Szepietowski JC; Samady JA; Schwartz RA
    J Med; 1999; 30(3-4):149-56. PubMed ID: 17312668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glucagonoma-associated dilated cardiomyopathy refractory to somatostatin analogue therapy.
    Barabas M; Huang-Doran I; Pitfield D; Philips H; Goonewardene M; Casey RT; Challis BG
    Endocrinol Diabetes Metab Case Rep; 2019 Mar; 2019():. PubMed ID: 30836327
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The glucagonoma syndrome].
    Rappersberger K; Wolff-Schreiner E; Konrad K; Wolff K
    Hautarzt; 1987 Oct; 38(10):589-98. PubMed ID: 2824404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Necrolytic migratory erythema in glucagonoma syndrome].
    Stark I; Mensing CH; Sander CA
    Hautarzt; 2008 Jan; 59(1):50-3. PubMed ID: 17549440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glucagonoma syndrome associated with necrolytic migratory erythema.
    Cardoso Filho Fde A; Feitosa RG; Fechine CO; Matos CM; Cardoso AL; Cardoso DL
    Rev Assoc Med Bras (1992); 2015; 61(3):203-6. PubMed ID: 26248239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glucagonoma presenting with necrolytic migratory erythema: the Glucagonoma syndrome.
    Schanz S; Schaefer J; Fierlbeck G
    Gastroenterology; 2005 Dec; 129(6):1816, 2131. PubMed ID: 16344049
    [No Abstract]   [Full Text] [Related]  

  • 57. Octreotide-responsive necrolytic migratory erythema in a patient with pseudoglucagonoma syndrome.
    Virani S; Prajapati V; Devani A; Mahmood MN; Elliott JF
    J Am Acad Dermatol; 2013 Feb; 68(2):e44-6. PubMed ID: 23317985
    [No Abstract]   [Full Text] [Related]  

  • 58. Delayed diagnosis of glucagonoma syndrome.
    Alkemade JA; van Tongeren JH; van Haelst UJ; Smals A; Steijlen PM; van de Kerkhof PC
    Clin Exp Dermatol; 1999 Nov; 24(6):455-7. PubMed ID: 10606947
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Glucagonoma: case report and literature review].
    das Neves MM; Martins Júnior EV; Gaburri AK; Chebli JM; Stávale JN; Herani Filho AK
    Arq Gastroenterol; 1996; 33(3):167-72. PubMed ID: 9201330
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravascular tumor: a previously unreported finding of glucagonoma.
    Geehan DM; Kapcala LP; Saberinia M; Scovill WA
    South Med J; 1997 Jul; 90(7):743-7. PubMed ID: 9225901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.